This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

A snapshot of the most highly ranked articles in developmental biology, from Faculty of 1000

Some of the most influential papers in 1992, according to data provided by the Philadelphia-based Institute for Scientific Information, were in immunology. This is not surprising, given the field's applications in stemming AIDS, cancer, and other pressing diseases. The most cited paper published within the last two years is from the Max Planck Institute for Biology in Tbingen, Germany (K. Falk, et al., Nature, 351:290, 1991). This paper, which by the end of February 1993 had been referred to i

Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.

The National Institute of Allergy and Infectious Diseases has named George W. Counts as head of the newly established Clinical Research Management Branch in the Treatment Research Program of NIAID’s Division of AIDS. Prior to the appointment, Counts, 54, had been a professor of medicine at the University of Washington, Seattle, since 1975. He also served as director of the Clinical Microbiology Laboratory at the Fred Hutchinson Cancer Research Center in Seat- tle from 1985 to 1989. Co

We have barely scratched the surface of itch science and what it indicates about our health.

Immunology Author: Neeraja Sankaran This year, the New York City-based Cancer Research Institute (CRI) honored three prominent scientists with its William B. Coley Awards for Distinguished Research, which recognize outstanding research in the field of cancer immunology. The awards were presented at a black-tie dinner on June 28. Malcolm A.S. Moore, a hematologist at Memorial Sloan-Kettering Cancer Center (MSKCC), New York, and Timothy A. Springer, a professor of pathology at the Center for Blo

The Sloan Kettering researcher used mutagenic screening to probe genes and molecular pathways, including Toll and Hedgehog, essential to development in fruit flies and mice.

The National Eye Institute (NEI) celebrates its 25th anniversary this year. But, as institute director Carl Kupfer notes, while its accomplishments over the years have more than justified its formation as a separate research agency of the National Institutes of Health, it took a bit of persuasion to carry out that vision. FAR-SIGHTED FOCUS: Cal Kupfer, the institute's first director, recounts NEI's past successes and looks forward to achieving new goals in treating eye disease. "In the 1950s,